Do not miss the only European edition of the flagship international platform and community for early-stage biotech and healthcare innovation stakeholders and organizations like yours.
See the website for full details on Membership in the TTS Global Initiative or Registration for the TTS Europe. www.ttsglobalinitiative.com
Europe's only interactive round-table summit of high-level, early-stage biotech innovation KOLs and decision-makers from across all of the key stakeholder groups; tech transfer, public research, patient organizations, foundations, venture capital, corporate venture, investment banks, start-ups, SMEs, big pharma, and industry.
TTS GLOBAL INITIATIVE
Founded in 2007, the TTS Global Initiative is the premier international Think Tank and platform bringing together Key Opinion Leaders from all of the critical stakeholders involved in biomedical sector healthcare technology transfer, broadly defined. In Europe, the USA, Australia, and Asia. Your organization should be among them.
The TTS Global Initiative has one primary objective: to foster innovation in healthcare by accelerating the translation of world-class life sciences and biomedical research from the lab to the patient and the market.
All TTS initiatives revolve around one central principal; that the best way to foster innovation is to bring together Key Opinion Leaders (KOLs) and Decision-Makers from all the stakeholder groups in healthcare innovation.
MEMBERSHIP _ TTS GLOBAL INITIATIVE
Become a Member of the TTS Global Initiative - full access to all 4 TTS Summits & all other TTS initiatives from just €799 for the full year!
SEE THE MEMBERSHIP PAGE FOR DETAILS -- there is no other platform in early-stage biotech and healthcare innovation offering anywhere near these benefits, and it is priced to break even on the actual cost of delivering the platform and benefits to your organization. CLICK http://www.ttsglobalinitiative.com/membership/ for full details and how to join.
Early registration until 21 March.
ENTENTE invitees receive special, further reduced rates providing access at the lowest possible rates for key biotech innovation, tech transfer and early-stage stakeholders. Register before 21 March for the early registration rates, and using the Code ENTE14 for an additional discount